TP53 and neoplasm: Likewise, enhanced MCT-1 activation in the p53-deficient cells impairs mitotic development, G2/M checkpoint and genomic stability upon microtubule disruption or DNA damage.27,28 Genetic mutations are thus accumulated progressively as a consequence of the MCT-1 oncogenic activation and the tumor suppressor dysfunction.